Sign in
4/A

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-15-000351

Options or other derivatives

  • Chief Financial Officer acquired 21,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hippel James · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-08-07 Grant or award : show line 1 in the form Stock Option (Right to Buy) +18,750 $108.49 2022-08-07 18,750 18,750 D
2015-08-07 Grant or award : show line 2 in the form Restricted Stock Unit +3,000 3,000 3,000 D
Loading xslF345X03/edgar.xml…